Assessment of Atorvastatin Effectiveness on Serum PSA Level in Hypercholesterolemic Males

The previous large retrospective studies demonstrated that treatment with Statins reduces both the incidence of prostate cancer by 50% and serum Prostate Specific Antigen (PSA) level up to 40%. However the main problem in those studies was the absence of control groups of men with hypercholesterolem...

Descrición completa

Detalles Bibliográficos
Main Authors: Iradj Khosropanah, Siavash Falahatkar, Babak Farhat, Zhoobin Heidari Bateni, Ahmad Enshaei, Ali Akbar Allahkhah, Darya Khosropanah
Formato: Artigo
Idioma:English
Publicado: Tehran University of Medical Sciences 2011-12-01
Series:Acta Medica Iranica
Subjects:
Acceso en liña:https://acta.tums.ac.ir/index.php/acta/article/view/3840